U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07071051) titled 'Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study' on July 08.
Brief Summary: This study evaluates the impact of calaspargase pegol (Cal-PEG) on the coagulation system in pediatric patients with acute lymphoblastic leukemia/lymphoma (ALL).
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
Childhood Acute Lymphoblastic Leukemia
Childhood Lymphoblastic Lymphoma
Intervention:
OTHER: Non-Interventional Study
Non-interventional study
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Mayo Clinic
Published by HT Digital Content Ser...